<SEC-DOCUMENT>0001104659-23-103545-index.html : 20230925 <SEC-HEADER>0001104659-23-103545.hdr.sgml : 20230925 <ACCEPTANCE-DATETIME>20230925165623 ACCESSION NUMBER: 0001104659-23-103545 CONFORMED SUBMISSION TYPE: SC 13G PUBLIC DOCUMENT COUNT: 2 FILED AS OF DATE: 20230925 DATE AS OF CHANGE: 20230925 GROUP MEMBERS: PARADIGM BIOCAPITAL ADVISORS GP LLC GROUP MEMBERS: PARADIGM BIOCAPITAL INTERNATIONAL FUND LTD. GROUP MEMBERS: SENAI ASEFAW, M.D. SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: Disc Medicine, Inc. CENTRAL INDEX KEY: 0001816736 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 851613057 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G SEC ACT: 1934 Act SEC FILE NUMBER: 005-91633 FILM NUMBER: 231276397 BUSINESS ADDRESS: STREET 1: 321 ARSENAL STREET, SUITE 101 CITY: WATERTOWN STATE: MA ZIP: 02472 BUSINESS PHONE: (617) 674-9274 MAIL ADDRESS: STREET 1: 321 ARSENAL STREET, SUITE 101 CITY: WATERTOWN STATE: MA ZIP: 02472 FORMER COMPANY: FORMER CONFORMED NAME: Gemini Therapeutics, Inc. /DE DATE OF NAME CHANGE: 20210209 FORMER COMPANY: FORMER CONFORMED NAME: FS Development Corp. DATE OF NAME CHANGE: 20200702 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: Paradigm Biocapital Advisors LP CENTRAL INDEX KEY: 0001855655 IRS NUMBER: 851451055 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G BUSINESS ADDRESS: STREET 1: 767 THIRD AVENUE, 17TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10017 BUSINESS PHONE: 646-970-2123 MAIL ADDRESS: STREET 1: 767 THIRD AVENUE, 17TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10017 </SEC-HEADER> <DOCUMENT> <TYPE>SC 13G <SEQUENCE>1 <FILENAME>tm2326849d1_sc13g.htm <DESCRIPTION>SC 13G <TEXT> Document 1 - file: tm2326849d1_sc13g.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-99.1 <SEQUENCE>2 <FILENAME>tm2326849d1_ex1.htm <DESCRIPTION>EXHIBIT 99.1 <TEXT> Document 2 - file: tm2326849d1_ex1.htm
</DOCUMENT> </SEC-DOCUMENT>